Hansoh Pharmaceutical Group Co. Ltd.

05/13/2021 | Press release | Distributed by Public on 05/13/2021 08:20

VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION OF AMEILE IN FIRST LINE EGFR-MUTATED NON-SMALL CELL LUNG CANCER ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION